Back to search
FDAFDA · Food and drugs·Recall number D-1485-2014

Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New York, NY 10017, NDC 0049-2710-30

Published August 6, 2014 · Recall initiated: June 19, 2014

Summary

FDA records drug Class III recall D-1485-2014, published August 6, 2014 and initiated June 19, 2014. Recalling firm: Pfizer Inc.; Status: Terminated; Reported quantity: 22,461 bottles; Lot: Lot # V130822; Exp 01/15. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Pfizer Inc.
Distributor
Nationwide (Continental USA and Puerto Rico). A portion of the bulk lot was supplied to Pfizer Germany for packaging into blisters for non- USA market. One of these lots in Germany was placed in stability having acceptable results, therefore are not part of the recall scope. Only the product distributed within US/PR market (bottles) is in the scope of this recall.
Lot
Lot # V130822; Exp 01/15
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Cardura XL (doxazosin mesylate extended release tablets, 4 mg, 30-count bottle, Rx only, Distributed by Roerig Division of Pfizer Inc., New York, NY 10017, NDC 0049-2710-30 recalled?

Yes. FDA published recall D-1485-2014 on August 6, 2014. Reported hazard: Failed Impurities/Degradation Specifications: Product from this lot may not meet specifications for a product degradant.

What should I do if I have this product?

Voluntary: Firm initiated · Letter